This is a working overview of Peptidomimetic, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-03-27. Anything still debated is marked as such rather than presented as settled.
Dihexa is a synthetic peptide that has been examined in laboratory and animal research. Its design is based on angiotensin IV, a naturally occurring peptide fragment produced in the body. The short name dihexa appears in scientific papers and online discussions, while the full chemical name describes a modified peptide chain. It is not a vitamin, mineral, or plant-derived compound. Suppliers typically present it as a research chemical rather than an approved medicine.
The full name often given is N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. This name indicates a chain containing tyrosine, isoleucine, and a six-carbon amino acid derivative. Databases list a CAS Registry Number and a molecular formula for the compound. The peptide is small compared with proteins, and its structure allows it to be studied in cell cultures and animal models. Exact identity depends on the supplier's synthesis and purification process. Minor impurities can remain after synthesis.
Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.
Development of dihexa followed from studies on angiotensin IV analogs and their effects on learning and memory. Researchers sought compounds with improved metabolic stability and brain penetration compared with natural peptides. In preclinical reports, dihexa was associated with changes in synaptic connectivity and performance on spatial tasks. These findings generated interest in its potential as a cognitive research tool. The work remains largely preclinical, and independent replication has been limited.
Regulatory and commercial contexts differ from clinical medicine. Dihexa is not approved as a drug by major agencies, and no published human trials establish its safety or efficacy. It is often sold as a research chemical labeled for laboratory use only. Suppliers may provide certificates of analysis, but purity and identity depend on the specific batch. Legal status varies by country and may treat such compounds as unapproved substances for human consumption.
| Property | Value | Notes |
|---|---|---|
| Common name | Dihexa | Shorthand used in research literature and supplier catalogs. |
| CAS Registry Number | 1401708-83-5 | Identifier assigned to the synthetic peptide. |
| Molecular formula | C27H44N4O5 | Reported formula; verify with a certificate of analysis. |
| Appearance | White to off-white powder | Typical form for lyophilized research peptides. |
| Typical storage | −20 °C or below, desiccated | Common condition for peptide stability. |
Discussion of dihexa in online communities sometimes outpaces the scientific record. Anecdotal reports are difficult to verify and may not distinguish effects from placebo or expectation. The absence of approved human data means long-term risks remain unknown. Researchers continue to investigate related compounds and pathways. Open questions include whether animal findings translate to humans and which biological targets matter most. No consensus exists on these points. Current reviews emphasize the need for rigorous clinical research.
Most published work on dihexa consists of preclinical studies using cell cultures or rodents. Reports have described effects on synaptic connectivity and performance on cognitive tasks in some animal models. These findings are generally presented as preliminary and require independent replication. Study designs, doses, and outcome measures vary across experiments, which complicates direct comparison. No large controlled human trials have established efficacy or safety for any medical use. At present, the evidence base is limited.
Regulatory agencies have not approved dihexa as a prescription drug or supplement. In many countries it falls into a gray area when sold for laboratory research. Buyers may encounter products marketed for research use only, which are not intended for human consumption. Purity and identity can vary between suppliers and batches. Certificates of analysis and independent testing are often recommended for research materials. Documentation helps verify what a vial contains.
Research on dihexa has primarily used rodent models and cultured cells. Common endpoints include dendritic spine density, synaptic protein expression, and performance on maze or avoidance tasks. Some studies report improvements in cognitive measures after scopolamine-induced deficits or in aged animals. These findings are interesting but come from a small body of work, and independent laboratories have not consistently replicated all reported effects. Larger, preregistered studies would help clarify which results are robust.
Human data for dihexa remain absent from peer-reviewed clinical literature. As a result, questions about absorption, distribution, metabolism, excretion, and long-term safety are unresolved. Discussions often appear in nootropic forums, where anecdotal reports cannot substitute for controlled trials. Researchers have called for more rigorous pharmacokinetic and toxicological studies before any clinical evaluation. Until such data exist, dihexa is best described as an investigational research compound rather than a proven intervention.
Dihexa is a synthetic compound studied in laboratory and animal models for effects on synaptic connectivity and cognitive performance. It is often described as a peptide analog because its structure incorporates amino acid residues linked to a hexanoic acid group. The molecule is not a naturally occurring human hormone or neurotransmitter. Its name appears in research literature and online discussions, but it has not been approved as a medicine by major regulatory agencies. Most information comes from preclinical experiments rather than controlled human trials.
The compound originated from work on angiotensin IV, a peptide fragment of the renin-angiotensin system. Researchers modified angiotensin IV-related structures to produce molecules with altered stability and activity. Dihexa emerged from that effort and was reported to promote dendritic spine growth in cultured neurons. Some studies link its effects to hepatocyte growth factor signaling and the c-Met receptor, while other work points to insulin-regulated aminopeptidase. The precise primary target remains a subject of investigation, and findings may depend on cell type, assay conditions, and species.
Body mass index (BMI) is acceptable for determining obesity for children two years of age and older. It is determined by the ratio of weight to height. The normal range for BMI in children vary with age and sex. While a BMI above the 85th percentile is defined as overweight, a BMI greater than or equal to the 95th percentile is defined as obesity by the Centers for Disease Control and Prevention (CDC). Obesity is further categorized as class 1 obesity with BMI at or above the 95th percentile to 119% of the 95th percentile, class 2 obesity with a BMI 120 to 139% of the 95% percentile and class 3 obesity which is 140% or greater of the 95th percentile. The CDC has published tables for determining this in children. The US Preventive Service Task Force reported that not all children with a high BMI need to lose weight, however. High BMI can identify a possible weight problem, but does not differentiate between fat or lean tissue. Additionally, BMI may mistakenly rule out some children who do have excess adipose tissue. It is therefore beneficial to supplement the reliability of a BMI diagnosis with additional screening tools such as adipose tissue or skin fold measurements.
=== Inherited Neurodegenerative Diseases === In 2022, a new autosomal-recessive disease was discovered that is caused by mutations of the CTR1 gene. The disease is characterized by profound deficiency of copper in the central nervous system and presents with infantile seizures and neurodegeneration. hCTR1 has been implicated in neurological disorders. Copper imbalance is a hallmark of various neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, where amyloid-β peptides bind copper and generate oxidative stress. Furthermore is's associated with Huntington’s disease, prion diseases, and Amyotrophic lateral sclerosis. The hCTR1-Atox1-ATP7A/B axis is also associated with Menkes disease and Wilson’s disease, in both cases the pathology is driven primarily by mutations in proteins that regulate copper homeostasis, most notably disease-causing mutations in ATP7A or ATP7B, which lead to systemic copper deficiency or copper overload. Moreover, the human eye, and particularly the retina, is composed of highly specialized neurons, and hCTR1 plays a vital role in maintaining copper homeostasis across ocular tissues. Increased hCTR1 expression has been reported in patients with Eales disease and copper has been identified as a major driver of vision loss in ischemic and diabetic retinopathies.
In 1997 General Charles Guthrie became Chief of the Defence Staff the head of the British armed forces. Lieutenant-General Cedric Delves was appointed commander of the Field Army and deputy commander in chief NATO Regional Headquarters Allied Forces North in 2002–2003.
== Clinical significance == The GPx1 allele with five Ala repeats is significantly associated with breast cancer risk. Kocabasoglu, et al., sought to investigate connections between oxidative stress genes, including GPX1, and Panic Disorder, an anxiety disorder characterized by random and unexpected attacks of intense fear. Although the GPX1 Pro198Leu polymorphism, in general, did not significantly correlate with panic disorder risk, the study found a plausible association of the C allele of the GPX1 Pro198Leu polymorphism, found to be more frequent in the female cohort, with PD development. Ergen and colleagues analyzed gene expression of oxidative stress genes, specifically GPX1, in colorectal tumors in comparison to healthy colorectal tissues. ELISA was utilized to quantify GPX1 protein expression levels in both tissue types, highlighting a 2-fold decrease in tumor tissue (p<0.05). In esophageal cancer, Chen and colleagues found that vitamin D, a known suppressor of GPX1 expression via the NF-κB signaling pathway, could help to decrease the proliferative, migratory, and invasive capabilities of esophageal cancer cells. Unlike in colorectal cancer, GPX1 expression in esophageal cancer cells is thought to drive aggressive growth and metastasis, but Vitamin D-mediated decrease in GPX1 prevents such growth.
Sources: en.wikipedia.org
treatment of serious infections caused by susceptible organisms resistant to penicillins, such as methicillin-resistant S. aureus (MRSA) and multidrug-resistant S. epidermidis (MRSE), treatment of infections in individuals with serious allergy to penicillins, treatment of pseudomembranous colitis caused by C. difficile; in particular, in cases of relapse or where the infection is unresponsive to metronidazole treatment (for this indication, vancomycin is given orally rather than intravenously), treatment of infections caused by Gram-positive microorganisms in patients with serious allergies to beta-lactam antimicrobials, antibacterial prophylaxis for endocarditis after certain procedures in penicillin-hypersensitive people at high risk, surgical prophylaxis for major procedures involving implantation of prostheses in institutions with a high rate of MRSA or MRSE, early in treatment as an empiric antibiotic for possible MRSA infection while waiting for culture identification of the infecting organism, halting the progression of primary sclerosing cholangitis and preventing symptoms; vancomycin does not cure the patient and success is limited, treatment of endophthalmitis by intravitreal injection for Gram-positive bacteria coverage; it has been used to prevent the condition but is not recommended due to the risk of side effects.
Decorative dried flower producer/growers and wholesalers hand-pick the decorative mature seeded pods/heads with or without the stalks for use in floral decorative arrangements. These are then mechanically dried at high temperatures in large kilns to render insects dead and the seeds unviable, so that the harvest consists almost entirely of the dried flowered seeded pods/heads (for ease of transport, artificial stems are added afterwards, e.g. bird seed wreath making, floral arrangements and wedding boutonnières or arts/craft projects). The seeds used for this market are chosen for the size and shape of the mature poppy seed pod/head and not alkaloid content. Many varieties, strains, and cultivars of Papaver somniferum are in existence, and the alkaloid content can vary significantly.
=== Active site === In addition to the Schiff base linkage, PLP is anchored to the active site of the enzyme via hydrogen bonding at the Tyr 207 and Glu237 residues. In addition, the phosphate oxygen atoms on the PLP molecule interact with the Arg99, Val269, Val270, and Thr310 residues. Mammalian BCATs show a unique structural CXXC motif (Cys315 and Cys318) sensitive to oxidizing agents and modulated through S-nitrosation, a post-translational modification that regulates cell signaling. Modification of these two cysteine residues via oxidation (in vivo/vitro) or titration (in vitro) has been found to inhibit enzyme activity, indicating that the CXXC motif is crucial to optimal protein folding and function. The sensitivity of both isoenzymes to oxidation make them potential biomarkers for the redox environment within the cell. Although the CXXC motif is present only in mammalian BCATs, the surrounding amino acid residues were found to be highly conserved in both prokaryotic and eukaryotic cells. Conway, Yeenawar et al. found that the mammalian active site contains three surfaces: surface A (Phe75, Tyr207 and Thr240), surface B (Phe30, Tyr141, and Ala314), and surface C (Tyr70, Leu153 and Val155, located on the opposite domain) that bind to the substrate in a Van der Waals-type interaction with the branched side chains of the amino acid substrates.
Major volcanic eruptions have an overwhelming effect on sulfate aerosol concentrations in the years when they occur: eruptions ranking 4 or greater on the Volcanic Explosivity Index inject SO2 and water vapor directly into the stratosphere, where they react to create sulfate aerosol plumes. Volcanic emissions vary significantly in composition, and have complex chemistry due to the presence of ash particulates and a wide variety of other elements in the plume. Only stratovolcanoes containing primarily felsic magmas are responsible for these fluxes, as mafic magma erupted in shield volcanoes doesn't result in plumes which reach the stratosphere. However, before the Industrial Revolution, dimethyl sulfide pathway was the largest contributor to sulfate aerosol concentrations in a more average year with no major volcanic activity. According to the IPCC First Assessment Report, published in 1990, volcanic emissions usually amounted to around 10 million tons in 1980s, while dimethyl sulfide amounted to 40 million tons. Yet, by that point, the global human-caused emissions of sulfur into the atmosphere became "at least as large" as all natural emissions of sulfur-containing compounds combined: they were at less than 3 million tons per year in 1860, and then they increased to 15 million tons in 1900, 40 million tons in 1940 and about 80 millions in 1980. The same report noted that "in the industrialized regions of Europe and North America, anthropogenic emissions dominate over natural emissions by about a factor of ten or even more".
Dial up Dial down Pendant up Pendant down Pendant left Pendant right Temperature (from 34 to 100 degrees Fahrenheit (1 to 38 °C)) Isochronism (the ability of the watch to keep time, regardless of the mainspring's level of tension) Positional adjustments are attained by careful poising (ensuring even weight distribution) of the balance-hairspring system as well as careful control of the shape and polish on the balance pivots. All of this achieves an equalization of the effect of gravity on the watch in various positions. Positional adjustments are achieved through careful adjustment of each of these factors, provided by repeated trials on a timing machine. Thus, adjusting a watch to position requires many hours of labor, increasing the cost of the watch. Medium grade watches were commonly adjusted to 3 positions (dial up, dial down, pendant up) while high grade watches were commonly adjusted to 5 positions (dial up, dial down, stem up, stem left, stem right) or even all 6 positions. Railroad watches were required, after 1908, to be adjusted to 5 positions. 3 positions were the general requirement before that time. Early watches used a solid steel balance. As temperature increased, the solid balance expanded in size, changing the moment of inertia and changing the timing of the watch. In addition, the hairspring would lengthen, decreasing its spring constant. This problem was initially solved through the use of the compensation balance. The compensation balance consisted of a ring of steel sandwiched to a ring of brass. These rings were then split in two places.
Sources: en.wikipedia.org
Purkinje cell dendrites Smooth endoplasmic reticulum Cell membrane Periglomerular cells in the olfactory bulb Cerebellar cortex Neurons in the brainstem, entorhinal and piriform cortices, and the habenula.
The county is named after the ancient Welsh Kingdom of Powys, which in the sixth century AD included the northern two-thirds of the area as well as most of Shropshire, Herefordshire and adjacent areas now in England, and came to an end when it was occupied by Llywelyn ap Gruffudd of Gwynedd during the 1260s. The uplands retain evidence of occupation from long before the Kingdom of Powys, and before the Romans, who built roads and forts across the area. There are 1130 identified burial mounds within the county, of varying styles and ages, dating from 4000 BC to 1000 BC, most of them belonging to the Bronze Age. Of these, 339 are scheduled monuments. Standing stones, most again dating to the Bronze Age, also occur in large numbers, 276 being found across the county, of which 92 are scheduled. From the Iron Age, the county has 90 scheduled hillforts and a further 54 enclosures and settlement sites. Powys is served by the Cambrian Line and Heart of Wales line which offer connections to major towns and cities such as Swansea, Wrexham, Shrewsbury, Birmingham, Wolverhampton, Manchester, Cardiff, Aberystwyth, London and Telford. The county used to be served by key railways such as the Mid-Wales Railway, Oswestry and Newtown Railway, Tanat Valley Light Railway, Llanfyllin Branch, Leominster and Kington Railway, Swansea Vale Railway and the Hereford, Hay and Brecon Railway, all of which offered connections to South Wales, Hereford, Oswestry, North Wales and West Wales but have all since closed.
Glover's Christian Scientists' Home." According to McClure's, there was a regular turnover of tenants and domestic staff, whom Eddy accused of stealing from the house; she blamed Richard Kennedy for using mesmerism to turn people against her. According to Peel, there was gossip about the attractive woman, the men who came and went, and whether she was engaged in witchcraft. She was hurt, he wrote, but made light of it: "Of course I believe in free love; I love everyone."
In a woman with much breast tissue, for whom submuscular emplacement is the recommended surgical therapy, the aesthetic results of a saline breast-prosthesis are a proportionate breast-size, a smooth contour to the breast hemisphere, and anatomic symmetry, like the therapeutic results achieved with a prosthetic breast filled with silicone-gel.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide modeled on angiotensin IV. It is used in laboratory and animal research, not as an approved medicine. Human effects remain poorly characterized.
It is produced by chemical synthesis, not extracted from plants or animals. Its design is based on a naturally occurring peptide fragment. Suppliers sell it as a research chemical.
No, dihexa is a modified analog of angiotensin IV. The two share a structural relationship but differ in chemical details. Research on one does not automatically apply to the other.
Dihexa is a synthetic peptidomimetic related to angiotensin IV. It is studied in preclinical research for effects on synaptic signaling and cognition. It is not an approved medication.